Kelly Lorraine Graham, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internal Medicine | 5 | 2021 | 996 | 1.370 |
Why?
|
| Patient Readmission | 6 | 2019 | 3106 | 1.300 |
Why?
|
| Internship and Residency | 7 | 2023 | 5761 | 1.100 |
Why?
|
| Academic Medical Centers | 5 | 2023 | 2749 | 0.810 |
Why?
|
| Lost to Follow-Up | 1 | 2022 | 108 | 0.790 |
Why?
|
| Problem-Based Learning | 1 | 2019 | 359 | 0.520 |
Why?
|
| Physicians | 2 | 2022 | 4538 | 0.460 |
Why?
|
| Educational Measurement | 1 | 2019 | 1205 | 0.410 |
Why?
|
| Leadership | 1 | 2020 | 1349 | 0.380 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 2275 | 0.370 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2010 | 413 | 0.310 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 928 | 0.250 |
Why?
|
| Program Evaluation | 1 | 2013 | 2484 | 0.250 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3143 | 0.210 |
Why?
|
| Primary Health Care | 4 | 2023 | 4537 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3248 | 0.210 |
Why?
|
| Breast | 1 | 2010 | 1950 | 0.200 |
Why?
|
| Pandemics | 1 | 2020 | 8274 | 0.180 |
Why?
|
| Time Factors | 5 | 2019 | 40040 | 0.160 |
Why?
|
| Quality of Health Care | 1 | 2013 | 4365 | 0.160 |
Why?
|
| Patient Care | 1 | 2022 | 638 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9393 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2021 | 1054 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2022 | 2656 | 0.110 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 385 | 0.110 |
Why?
|
| Humans | 17 | 2023 | 739219 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2017 | 1165 | 0.090 |
Why?
|
| Medicare | 2 | 2018 | 6497 | 0.080 |
Why?
|
| Nitrites | 1 | 2008 | 161 | 0.080 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2018 | 1206 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2212 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2023 | 76632 | 0.070 |
Why?
|
| United States | 3 | 2022 | 69568 | 0.070 |
Why?
|
| Epithelium | 1 | 2010 | 1684 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2015 | 1780 | 0.070 |
Why?
|
| Aspirin | 1 | 2017 | 3268 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2015 | 1849 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 57639 | 0.070 |
Why?
|
| Female | 7 | 2019 | 378808 | 0.060 |
Why?
|
| Male | 7 | 2019 | 348967 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2275 | 0.060 |
Why?
|
| Adult | 5 | 2019 | 213375 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 3066 | 0.060 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 575 | 0.060 |
Why?
|
| Data Collection | 1 | 2013 | 3340 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 20672 | 0.060 |
Why?
|
| Aged | 4 | 2018 | 162667 | 0.060 |
Why?
|
| Middle Aged | 5 | 2018 | 212833 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2183 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2015 | 3286 | 0.050 |
Why?
|
| Medicaid | 1 | 2015 | 2711 | 0.050 |
Why?
|
| Length of Stay | 1 | 2015 | 6294 | 0.050 |
Why?
|
| Risk Factors | 2 | 2018 | 71972 | 0.040 |
Why?
|
| Research Design | 1 | 2015 | 5959 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2022 | 40801 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 40385 | 0.030 |
Why?
|
| Pravastatin | 1 | 2017 | 395 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 53036 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15069 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 1143 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2023 | 3514 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 979 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1127 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2008 | 61 | 0.020 |
Why?
|
| Anions | 1 | 2008 | 133 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 562 | 0.020 |
Why?
|
| COS Cells | 1 | 2008 | 1159 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2008 | 1094 | 0.010 |
Why?
|
| Amino Acids | 1 | 2008 | 1727 | 0.010 |
Why?
|
| Estradiol | 1 | 2008 | 2021 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5884 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 5863 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23292 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16624 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 168358 | 0.000 |
Why?
|